Mendelspod Podcast
The Pre-Symptomatic Space with Patrick Short, Sano Genetics
Apr 25, 2024
Patrick Short, CEO of Sano Genetics, discusses overcoming challenges in genetic research, emphasizing accessibility and pre-symptomatic treatments for conditions like ALS. They also explore early detection strategies using biomarkers for diseases like Alzheimer's and Braca mutations.
05:41
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Facilitating large-scale genetic studies to make research more accessible and overcome barriers participants face.
- Exploring markers beyond gene presence for early detection and treatment of diseases, emphasizing the importance of pre-symptomatic interventions.
Deep dives
Enhancing Access to Genetics Research at Sano Genetics
Sano Genetics, led by CEO Patrick Short, focuses on facilitating large-scale genetic studies to overcome the barriers participants commonly face, such as physical site visits and lack of result feedback. Short's personal experience with a rare kidney disease underlines the importance of making genetics research more accessible. The company aims to simplify participation and gather extensive datasets essential for research. Noteworthy examples like ALS genetic studies highlight the significance of enabling pre-symptomatic treatments and utilizing biomarkers for early detection.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
